BiotechZone - Online Marketplace

Aiming to change the time-consuming way how scientists buy lab products and services, we created the “eBay” for Biotech.

Dreaming about a one-stop-shop for Science in the past, as students, BiotechZone provides an entirely new e-Commerce experience for Biotech, allowing the search and order on a single website for any lab product or service, to save time when searching and make money when selling, effortlessly.

BiotechZone is the World’s First B2B Marketplace for Biotechnology, Life Sciences and Laboratory Technology, joining verified suppliers, service providers and science professionals. With unique science-tailored features, researchers can search, in an easier and faster way, by thousands of technical features and specifications, compare and review detailed listings, and buy, directly to vendors in a single checkout (avoiding multiple vendors' websites), biological products, lab consumables, chemicals, reagents, equipment, instruments, software, services and facilities, centralizing and streamlining the procurement processes, managing orders and controlling expenditures in multiple user sub-accounts.

Vendors can create a Free Online Store and add unlimited products and services for free, benefiting from advanced registration forms connected to world-class scientific databases. They are able to set ‘sales zones’ and comply with distribution agreements already in place, without inducing any geographical distribution conflict, and start selling online to new markets which don’t have any distributor - BiotechZone is perfectly suitable both for manufacturers and distributors. When a sale occurs, a small and flat percentage fee is charged (success fee). It’s free to sign up and there are no subscription fees.

BiotechZone represents an innovative opportunity for biotech companies and institutions to maximize exposure on a specialized platform and achieve internationalization by selling worldwide 24/7, reaching new customers, and, therefore, boost sales and increase profits. Similarly, smaller or newer companies or institutions can compete equally in the booming global biotech market, estimated to grow at 11.6% CAGR and “reach a value worth of USD 414.5 billion by the end of 2017” according to Transparency Market Research (2013).